Publications by authors named "Julie Leidecker"
Article Synopsis
- Hyperphosphatemia is a common issue in dialysis patients with end-stage kidney disease (ESKD) due to imbalanced phosphate intake and removal, leading researchers to investigate an app that customizes phosphate binder doses based on meal content.
- The study involved 80 ESKD patients who were either managed by a traditional multidisciplinary renal team or through the OkKidney app, monitoring serum phosphate levels over 3 months.
- Results showed no significant difference in phosphate control between the app and standard care, indicating that the app provided similar management without clear advantages over personal dietary support.
Background: Patients treated with peritoneal dialysis (PD) are at increased risk of developing mechanical complications such as dialysate leaks and hernias thought to be partially related to an increase in intra-abdominal pressure (IAP) secondary to dialysate in the abdomen. However, measurement of IAP requires specialized equipment that is not readily available in the home dialysis unit.
Objectives: To develop a reliable method of measuring IAP in PD patients that could be easily used in the home dialysis unit.
Background: Hyperphosphatemia is associated with adverse outcomes in patients treated with peritoneal dialysis (PD). We have shown that a fixed meal phosphate binder dosing schedule is not appropriate. The purpose of this study was to evaluate the beta version of OkKidney, a phosphate counting app that matches meal phosphate content with binder dose.
View Article and Find Full Text PDF